Browsing by Author Fock, K.M.

Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
2006A randomized, placebo-controlled trial of thymosin-α1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis BLim, S.G. ; Wai, C.-T. ; Lee, Y.M. ; Dan, Y.Y.; Sutedja, D.S.; Wee, A. ; Suresh, S.; Wu, Y.J.; Machin, D.; Lim, C.C.; Fock, K.M.; Koay, E.; Bowden, S.; Locarnini, S.; Ishaque, S.M.
2006A randomized, placebo-controlled trial of thymosin-α1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis BLim, S.G. ; Wai, C.-T. ; Lee, Y.M. ; Dan, Y.Y.; Sutedja, D.S.; Wee, A. ; Suresh, S.; Wu, Y.J.; Machin, D.; Lim, C.C.; Fock, K.M.; Koay, E. ; Bowden, S.; Locarnini, S.; Ishaque, S.M.
2001Autoimmune hepatitis in Singapore: A rare syndrome affecting middle-aged womenLee, Y.M. ; Teo, E.K.; Ng, T.M.; Khor, C.; Fock, K.M.
Jun-1995Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.Guan, R. ; Ng, H.S.; Fock, K.M.; Ho, K.Y.; Yap, I. ; Kang, J.Y. ; Chow, W.C.; Chew, C.N.; Ng, C.; Teo, C.J.
1995Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.Guan, R. ; Ng, H.S.; Fock, K.M.; Ho, K.Y. ; Yap, I. ; Kang, J.Y. ; Chow, W.C.; Chew, C.N.; Ng, C.; Teo, C.J. 
2008Proton pump inhibitors: Do differences in pharmacokinetics translate into differences in clinical outcomes?Fock, K.M.; Ang, T.L.; Bee, L.C.; Lee, E.J.D. 
Oct-2010Singapore armed forces medical corps-ministry of health clinical practice guidelines: Management of heat injuryLee, L.; Fock, K.M.; Lim, C.L.F.; Ong, C.L.F.; Poon, B.H.; Pwee, K.H. ; O'Muircheartaigh, C.R.; Seet, B.; Tan, C.L.B.; Teoh, C.S.
2000Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: Results of a multicentre study in South-East AsiaFock, K.M.; Chelvam, P.; Lim, S.G.